Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 2 , Pages 71-81 , February 2010

Isoprostane nomenclature: Inherent problems may cause setbacks for the development of the isoprostanoid field

Received 25 September 2009 ,Revised 29 November 2009 ,Accepted 30 November 2009.

References 

  1. Taber DF, Morrow JD, Roberts JJL. A nomenclature system for isoprostanes. Prostaglandins. 1997;53:63–67
  2. Rokach J, Khanapure SP, Hwang S-W, Adiyaman M, Lawson JA, FitzGerald GA. Nomenclature of isoprostanes: a proposal. Prostaglandins. 1997;54:853–873
  3. Mueller MJ. Radically novel prostaglandins in animals and plants: the isoprostanes. Chem. Biol. 1998;5:323–333
  4. Nelson NA. Prostaglandin nomenclature. J. Med. Chem. 1974;17:911–918
  5. Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 1998;273:13605–13612
  6. Parchmann S, Mueller MJ. Evidence for the formation of dinor isoprostanes E1 from α-linolenic acid in plants. J. Biol. Chem. 1998;273:32650–32655
  7. Imbusch R, Mueller MJ. Analysis of oxidative stress and wound-inducible dinor isoprostanes F1 (phytoprostanes F1) in plants. Plant Physiol. 2000;124:1293–1303
  8. Krischke M, Loeffler C, Mueller MJ. Biosynthesis of 13,14-dehydro-12-oxo-phytodienoic acid and related cyclopentenones via the phytoprostane D1 pathway. Phytochemistry. 2003;62:351–358
  9. Yin H, Morrow JD, Porter NA. Identification of a novel class of endoperoxides from arachidonate autoxidation. J. Biol. Chem. 2004;279:3766–3776
  10. Waugh RJ, Morrow JD, Roberts LJ, Murphy RC. Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat. Free Radic. Biol. Med. 1997;23:943–954
  11. Yin H, Musiek ES, Gao L, Porter NA, Morrow JD. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J. Biol. Chem. 2005;280:26600–26611
  12. Imbusch R, Mueller MJ. Formation of isoprostane F2-like compounds (phytoprostanes F1) from α-linolenic acid in plants. Free Radic. Biol. Med. 2000;28:720–726
  13. Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA. 1974;71:345–349
  14. Hamberg M, Fredholm BB. Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. Biochim. Biophys. Acta. 1976;431:183–189
  15. Fitzpatrick FA, Wynalda MA. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J. Biol. Chem. 1983;258:11713–11718
  16. Maxey KM, Hessler E, MacDonald J, Hitchingham L. The nature and composition of 15-deoxy-(delta)12,14PGJ2. Prostaglandins Other Lipid Mediat. 2000;62:15–21
  17. Negishi M, Sugimoto Y, Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta. 1995;1259:109–119
  18. Ni F, So SP, Cervantes V, Ruan KH. A profile of the residues in the second extracellular loop that are critical for ligand recognition of human prostacyclin receptor. FEBS J. 2008;275:128–137
  19. Li Y, Zhu F, Vaidehi N, Goddard WA, Sheinerman F, Reiling S, et al. Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. J. Am. Chem. Soc. 2007;129:10720–10731
  20. Ungrin MD, Carriere MC, Denis D, Lamontagne S, Sawyer N, Stocco R, et al. Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor. Mol. Pharmacol. 2001;59:1446–1456
  21. Jahn U, Galano JM, Durand T. Beyond prostaglandins—chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids. Angew. Chem. Int. Ed. Engl. 2008;47:5894–5955
  22. Hou X, Roberts LJ, Gobeil F, Taber D, Kanai K, Abran D, et al. Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature. Free Radic. Biol. Med. 2004;36:163–172
  23. Janssen LJ. Isoprostanes: generation, pharmacology, and roles in free-radical-mediated effects in the lung. Pulm. Pharmacol. Ther. 2000;13:149–155
  24. Janssen LJ, Tazzeo T. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J. Pharmacol. Exp. Ther. 2002;301:1060–1066
  25. Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 2001;21:185–210
  26. M. J. Mueller, S. Berger, Reactive electrophilic oxylipins: pattern recognition and signalling. Phytochemistry (2009)
  27. Uchida K, Shibata T. 15-deoxy-(delta)12,14PGJ2: an electrophilic trigger of cellular responses. Chem. Res. Toxicol. 2008;21:138–144
  28. Itoh T, Fairall L, Amin K, Inaba Y, Szanto A, Balint BL, et al. Structural basis for the activation of PPAR gamma by oxidized fatty acids. Nat. Struct. Mol. Biol. 2008;15:924–931
  29. Dueckershoff K, Mueller S, Mueller MJ, Reinders J. Impact of cyclopentenone–oxylipins on the proteome of Arabidopsis thaliana. Biochim. Biophys. Acta. 2008;1784:1975–1985
  30. Mueller S, Hilbert B, Dueckershoff K, Roitsch T, Krischke M, Mueller MJ, et al. General detoxification and stress responses are mediated by oxidized lipids through TGA transcription factors in arabidopsis. Plant Cell. 2008;20:768–785
  31. Loeffler C, Berger S, Guy A, Durand T, Bringmann G, Dreyer M, et al. B1-phytoprostanes trigger plant defense and detoxification responses. Plant Physiol. 2005;137:328–340

PII: S0952-3278(09)00203-8

doi: 10.1016/j.plefa.2009.11.007

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 2 , Pages 71-81 , February 2010

Article Tools

* Image Usage & Resolution